References
- CSERNI G. What is a positive sentinel lymph node in a breast cancer patient ? A practical approach. Breast, 2007: 16 (2): 152–160.
- Benson J. R., Querci della Rovere G. Management of the axilla in women with breast cancer. Breast, 2007: 16 (2): 130–136.
- Reitsamer R., Peintinger F., Prokop E. et al. 200 Sentinel lymph node biopsies without axillary lymph node dissection-no axillary recurrences after a 3-year follow-up. Br J Canc, 2004, 90 (8): 1551–1554.
- Schwartz G. F. Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update. Breast J, 2004, 10 (2): 85–88.
- Hill A. D, Tran K. N, Akhurst T. et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg, 1999, 229 (4): 528–535.
- Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., Intra M., Veronesi P., Robertson e., Maisonneuve P., Renne G., De Cicco C., De Lucia F., Gennari R. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 2003, 349 (6): 546–553.
- Cox C. E., Pendas S., Cox J. M. et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg, 1998, 227 (5): 645–651.
- Bland K. I. Microstaging of sentinel lymph nodes. Ann Surg Oncol, 1999, 6 (1): 15–16.
- Cserni G., Amendoeira I., Apostolikas N., Bellocq J. L., Bianchi S., Bussolati G. et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. European Journal of Cancer, 2003, 39: 1654–1667.
- Hunt K. K., Yi M., Mittendorf E. A., Guerrero C., Babiera G. V., Bedrosian I., Hwang R. F., Kuerer H. M., Ross M. I., Meric-Bernstam F. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg, 2009.
- Manecksha R., Hill A. D., Dijkstra B. Value of sentinel node biopsy in the management of breast cancer. Ir J Med Sci, 2001, 170 (4): 233–235.
- Dowling C., Hill A. D. Sentinel lymph node biopsy in breast cancer. Surgeon, 2004, 2 (5): 273–276.
- Giobuin S. M., Kavanagh D. O., Myers E., Doherty A. O., Quinn C. M., Crotty T., Evoy D., McDermott E. The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer. Eur J Surg Oncol, 2009.
- Ozmen V., Cabioglu N. Sentinel lymph node biopsy for breast cancer: current controversies. Breast J, 2006, 12 (S2), 134–142.
- Zakaria S., Degnim A. C., Kleer C. G. et al. Sentinel lymph node biopsy for breast cancer: How many nodes are enough ? J Surg Oncol, 2007, 96 (7): 554–559.
- Yi M., Meric-Bernstam F., Ross M. I., Akins J. S., Hwang R. F., Lucci A., Kuerer H. M., Babiera G. V., Gilcrease M. Z., Hunt K. K. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer ? Cancer, 2008, 113 (1): 30–31.
- Fleming F. J., Hill A. D., Kavanagh D. et al. Intradermal radioisotope injection optimises sentinel lymph node identification in breast cancer. EJSO, 2003, 29 (10): 835–838.